iSchemaView, Inc.

11 patents currently held · Updated Nov 14, 2026

1 more in force is now held by another company

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Ending by 2030

Jul 2039

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Apr 10, 2027
The maintenance fee for Identifying vessel occlusions using spatial patterns (US 11,783,481) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
1 fee due Aug 13, 2027
The maintenance fee for Assessment of facial paralysis and gaze deviation (US 11,896,375) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

2 of the patents on this record were granted since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 11,229,367	Systems and methods for analytical comparison and monitoring of aneurysms In force Term ends Jul 18, 2039 · From the USPTO record	In force	Term ends Jul 18, 2039	From the USPTO record
US 11,191,505	Analysis of Intracranial Blood Vessels In force Term ends May 1, 2040 · Medium confidence	In force	Term ends May 1, 2040	Medium confidence
US 12,758,174	Analysis of Intracranial Blood Vessels In force Term ends May 1, 2040 · High confidence	In force	Term ends May 1, 2040	High confidence
US 11,406,300	Assessment of facial paralysis and gaze deviation In force Term ends Apr 29, 2041 · From the USPTO record	In force	Term ends Apr 29, 2041	From the USPTO record
US 11,896,375	Assessment of facial paralysis and gaze deviation In force Ends no later than Apr 29, 2041 · From the USPTO record	In force	Ends no later than Apr 29, 2041	From the USPTO record
US 11,295,448	Concurrent display of hemodynamic parameters and damaged brain tissue In force Term ends Jul 28, 2041 · From the USPTO record	In force	Term ends Jul 28, 2041	From the USPTO record
US 11,348,241	Identifying vessel occlusions using spatial patterns In force Term ends Oct 14, 2041 · From the USPTO record	In force	Term ends Oct 14, 2041	From the USPTO record
US 11,783,481	Identifying vessel occlusions using spatial patterns In force Ends no later than Oct 14, 2041 · From the USPTO record	In force	Ends no later than Oct 14, 2041	From the USPTO record
US 12,150,801	Analysis of Intracranial Blood Vessels In force Term ends Jul 28, 2043 · High confidence	In force	Term ends Jul 28, 2043	High confidence
US 12,561,798	Concurrent Display of Hemodynamic Parameters and Damaged Brain Tissue In force Term ends Aug 7, 2043 · Medium confidence	In force	Term ends Aug 7, 2043	Medium confidence

10 of 11 patents shown.

Pro members see all 11.

Pro members: see all 11 patents

Also on record, not counted in the 11: 1 patent in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 no status recorded

List them